1. H. H. Tallan, S. Moore, and W. H. Stein. N-Acetyl-L-aspartic acid in brain. J. Biol. Chem. 219, 257-264 (1956).

2. A. Curatolo, P. D'Arcangelo, and A. Lino. Distribution of N-acetyl-aspartic and N-acetyl-aspartyl-glutamic acids in nervous tissue. J. Neurochem. 12, 339-342 (1965).

3. J. Hughes, T. Smith, B. Morgan, and L. Fothergill. Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci. 16, 1753-1758 (1975).

4. W. Vale, P. Brazeau, G. Grant, A. Nussey, R. Burgus, J. Rivier, N. Ling, and R. Guillemin. Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 275, 2913-2916 (1972).

5. K. J. Koller, R. Zaczek, and J. T. Coyle. W-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 43, 1136-1142 (1984).

6. K. J. Koller and J. T. Coyle. Ontogenesis of N-acetyl-aspartate and N-acetyl-aspartyl- glutamate in rat brain. Brain Res. 317, 137-140 (1984).

7. J. M. H. ffrench-Mullen, K. J. Koller, R. Zaczek, J. T. Coyle, N. Hori, and D. O. Carpenter. N-acetyl-aspartylglutamate: possible role as the neurotransmitter of the lateral olfactory tract. Proc. Natl. Acad. Sci. USA 82, 3897-3900 (1985).

8. G. C. Tsai and J. T. Coyle. N-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46, 531-540 (1995).

9. M. L. Simmons, C. G. Frondoza, and J. T. Coyle. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37-45 (1991).

10. J. R. Moffett, M. A. A. Namboodiri, C. B. Cangro, and J. H. Neale. Immunohistochemical localization of N-acetylaspartate in rat brain. NeuroReport 2, 131-134 (1991).

11. A. R. Guimaraes, P. Schwartz, M. R. Prakash, C. A. Carr, U. V. Berger, B. G. Jenkins, J. T. Coyle, and R. G. Gonzalez. Quantitative in vivo 'H nuclear magnetic resonance spectroscopic imaging of neuronal loss in rat brain. Neuroscience 69, 1095-1101 (1995).

12. D. J. Meyerhoff, S. MacKay, L. Bachman, N. Poole, W. P. Dillon, M. W. Weiner, and G. Fein. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virusseropositive individuals: In vivo *H magnetic resonance spectroscopic imaging. Neurology 43, 509-515 (1993).

13. J. R. Moffett, M. A. A. Namboodiri, and J. H. Neale. Enhanced carbodiimide fixation for immunohistochemistry: Application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J. Histochem. Cytochem. 41, 559-570 (1993).

14. L. A. Passani, J. P. G. Vonsattel, and J. T. Coyle. Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease. Brain Res. 772, 9-22 (1997).

15. C. G. Frondoza, S. Logan, G. Forloni, and J. T. Coyle. Production and characterization of monoclonal antibodies to W-acetyl-aspartyl-glutamate. J. Histochem. Cytochem. 38, 493-502 (1990).

16. G. Forloni, R. Grzanna, R. D. Blakely, and J. T. Coyle. Co-localization of W-acetylaspartylglutamate in central cholinergic, noradrenergic and serotonergic neurons. Synapse 1, 455-460 (1987).

17. K. J. Anderson, M. A. Borja, C. W. Cotman, J. R. Moffett, M. A. A. Namboodiri, and J. H. Neale. W-acetylaspartylglutamate identified in the rat retinal ganglion cells and their projections in the brain. Brain Res. 411, 172-177 (1987).

18. K. J. Anderson, D. T. Monaghan, C. B. Cangro, M. A. A. Namboodiri, J. H. Neale, and C. W. Cotman. Localization of W-acetylaspartylglutamate-like immunoreactivity in selected areas of the rat brain. Weurosci. Lett. 72, 14-20 (1986).

19. S. B. Tieman, C. B. Cangro, and J. H. Neale. W-Acetylaspartylglutamate immunoreactivity in neurons of the cat's visual system. Brain Res. 420, 188-193 (1987).

20. L. C. Williamson and J. H. Neale. Ultrastructural localization of W-acetylaspartylglutamate in vesicles of retinal neurons. Brain Res. 456, 375-381 (1988).

21. G. Tsai, B. L. Stauch, J. J. Vornov, J. K. Deshpande, and J. T. Coyle. Selective release of W-acetylaspartylglutamate from rat optic nerve terminals in vivo. Brain Res. 518, 313-316 (1990).

22. L. C. Williamson, D. A. Eagles, M. J. Brady, J. R. Moffett, M. A. A. Namboodiri, and J. H. Neale. Localization and synaptic release of W-acetylaspartylglutamate in the chick retina and optic tectum. Eur. J. Weurosci. 3, 441-451 (1991).

23. U. V. Berger, R. E. Carter, and J. T. Coyle. The immunocytochemical localization of W-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase, and the NMDAR- 1 receptor at a vertebrate neuro-muscular junction. Weuroscience 64, 847-850 (1995).

24. E. R. Whittemore and J. F. Koerner. An explanation for the purported excitation of piriform cortical neurons by W-acetyl-L-aspartyl-L-glutamic acid (NAAG). Proc. Watl. Acad. Sci. USA 86, 9602-9605 (1989).

25. G. L. Westbrook, M. L. Mayer, M. A. A. Namboodiri, and J. H. Neale. High concentrations of W-acetyl-aspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture. J. Weurosci. 6, 3385-3392 (1986).

26. P. Q. Trombley and G. L. Westbrook. Excitatory synaptic transmission in cultures of rat olfactory bulb. J. Weurophysiol. 64, 598-606 (1990).

27. M. Sekiguchi, K. Wada, and R. J. Wenthold. W-Acetylaspartylglutamate acts as an agonist upon homomeric NMDA receptor (NMDAR1) expressed in Xenopus oocytes. FEBS Lett. 311, 285-289 (1992).

28. R. Bergeron, J. T. Coyle, G. Tsai, and R. W. Greene. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Weuropsychopharmacology 30, 716 (2005).

29. B. Wroblewska, J. T. Wroblewski, S. Pshenichkin, A. Surin, S. E. Sullivan, and J. H. Neale. W-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Weurochem. 69, 174-181 (1997).

30. J. Bischofberger and D. Schild. Glutamate and W-acetylaspartylglutamate block HVA calcium currents in frog olfactory bulb interneurons via an mGluR2/3- like receptor. J. Weurophysiol. 76, 2089-2092 (1996).

31. N. Riveros and F. Orrego. A study of possible excitatory effects of W-acetylaspartylglutamate in different in vivo and in vitro preparations. Brain Res. 299, 393-395 (1984).

32. R. D. Blakely, M. B. Robinson, R. C. Thompson, and J. T. Coyle. Hydrolysis of the brain dipeptide W-acetyl-L-aspartyl-L-glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on W-acetylated-a-linked acidic dipeptidase activity. J. Weurochem. 50, 1200-1209 (1988).

33. B. S. Slusher, M. B. Robinson, G. Tsai, M. L. Simmons, S. S. Richards, and J. T. Coyle. Rat brain W-acetylated a-linked acidic dipeptidase activity. Purification and immunologic characterization. J. Biol. Chem. 265, 21297-21301 (1990).

34. R. E. Carter, A. R. Feldman, and J. T. Coyle. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Watl. Acad. Sci. USA 93, 749-753 (1996).

35. H. S. Speno, R. Luthi-Carter, W. L. Macias, S. L. Valentine, A. R. Joshi, and J. T. Coyle. Site-directed mutagenesis of predicted active site residues in glutamate carboxypeptidase II. Mol. Pharmacol. 55, 179185 (1999).

36. C. H. Halsted, E. Ling, R. Luthi-Carter, J. A. Villanueva, J. M. Gardner, and J. T. Coyle. Folylpoly-gamma -glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J. Biol. Chem. 273, 20417-20424 (1998).

37. C. W. Tiffany, R. G. Lapidus, A. Merion, D. C. Calvin, and B. S. Slusher. Characterization of the enzymatic activity of PSM: Comparison with brain NAALADase. Prostate 39, 28-35 (1999).

38. U. V. Berger, R. Luthi-Carter, L. A. Passani, S. Elkabes, I. Black, C. Konradi, and J. T. Coyle. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J. Comp. Neurol. 415, 5264 (1999).

39. R. Luthi-Carter, U. V. Berger, A. K. Barczak, M. Enna, and J. T. Coyle. Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc. Natl. Acad. Sci. USA 95, 3215-3220 (1998).

40. U. V. Berger, R. E. Carter, M. McKee, and J. T. Coyle. N-acetylated alpha-linked acidic dipeptidase is expressed by non-myelinating Schwann cells in the peripheral nervous system. J. Neurocytol. 24, 99-109 (1995).

41. D. J. Bacich, E. Ramadan, D. S. O'Keefe, N. Bukhari, I. Wegorzewska, O. Ojeifo, R. Olszewski, C. C. Wrenn, T. Bzdega, B. Wroblewska, W. D. W. Heston, and J. H. Neale. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate. J. Neurochem. 83, 20-29 (2002).

42. D. S. O'Keefe, S. L. Su, D. J. Bacich, Y. Horiguchi, Y. Luo, C. T. Powell, D. Zandvliet, P. J. Russell, P. L. Molloy, N. J. Nowak, T. B. Shows, C. Mullins et al. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim. Biophys. Acta 1443, 113-127 (1998).

43. T. Bzdega, S. L. Crowe, E. R. Ramadan, K. H. Sciarretta, R. T. Olszewski, O. A. Ojeifo, V. A. Rafalski, B. Wroblewska, and J. H. Neale. The cloning and characterization of a second brain enzyme with NAAG peptidase activity. J. Neurochem. 89, 627-635 (2004).

Was this article helpful?

0 0

Post a comment